MedTrace Logo

Treatment of Ulcerative Colitis With a Combination of Lactobacillus Rhamnosus and Lactobacillus Acidophilus.

NCT00374725 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2006-09-11

No results posted yet for this study

Summary

In this trial we test the hypothesis that a probiotic containing Lactobacillus acidophilus and Lactobacillus rhamnosus is an effective therapy for patients with ulcerative colitis.

Conditions

Interventions

BEHAVIORAL

Administration of probiotic (L. rhamnosus and L. acidophilus)

Sponsors & Collaborators

  • University of Southern Denmark

    collaborator OTHER

  • Crohn's and Colitis Foundation

    collaborator OTHER

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Lone G Klinge, MD · Odense University Hospital

  • Jens Kjeldsen, MD, PhD · Odense University Hospital

  • Karsten Lauritsen, MD, Dr.med. · Odense University Hospital

  • Lisbeth Ambrosius, MD,Dr.med. · Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-02-28
Completion
2006-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00374725 on ClinicalTrials.gov